AIMS: The aim of this study was to derive and validate the SCORE2-Older Persons (SCORE2-OP) risk model to estimate 5- and 10-year risk of cardiovascular disease (CVD) in individuals aged over 70 years in four geographical risk regions. METHODS AND RESULTS: Sex-specific competing risk-adjusted models for estimating CVD risk (CVD mortality, myocardial infarction, or stroke) were derived in individuals aged over 65 without pre-existing atherosclerotic CVD from the Cohort of Norway (28 503 individuals, 10 089 CVD events). Models included age, smoking status, diabetes, systolic blood pressure, and total- and high-density lipoprotein cholesterol. Four geographical risk regions were defined based on country-specific CVD mortality rates. Models were recalibrated to each region using region-specific estimated CVD incidence rates and risk factor distributions. For external validation, we analysed data from 6 additional study populations {338 615 individuals, 33 219 CVD validation cohorts, C-indices ranged between 0.63 [95% confidence interval (CI) 0.61-0.65] and 0.67 (0.64-0.69)}. Regional calibration of expected-vs.-observed risks was satisfactory. For given risk factor profiles, there was substantial variation across the four risk regions in the estimated 10-year CVD event risk. CONCLUSIONS: The competing risk-adjusted SCORE2-OP model was derived, recalibrated, and externally validated to estimate 5- and 10-year CVD risk in older adults (aged 70 years or older) in four geographical risk regions. These models can be used for communicating the risk of CVD and potential benefit from risk factor treatment and may facilitate shared decision-making between clinicians and patients in CVD risk management in older persons. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: The aim of this study was to derive and validate the SCORE2-Older Persons (SCORE2-OP) risk model to estimate 5- and 10-year risk of cardiovascular disease (CVD) in individuals aged over 70 years in four geographical risk regions. METHODS AND RESULTS: Sex-specific competing risk-adjusted models for estimating CVD risk (CVD mortality, myocardial infarction, or stroke) were derived in individuals aged over 65 without pre-existing atherosclerotic CVD from the Cohort of Norway (28 503 individuals, 10 089 CVD events). Models included age, smoking status, diabetes, systolic blood pressure, and total- and high-density lipoprotein cholesterol. Four geographical risk regions were defined based on country-specific CVD mortality rates. Models were recalibrated to each region using region-specific estimated CVD incidence rates and risk factor distributions. For external validation, we analysed data from 6 additional study populations {338 615 individuals, 33 219 CVD validation cohorts, C-indices ranged between 0.63 [95% confidence interval (CI) 0.61-0.65] and 0.67 (0.64-0.69)}. Regional calibration of expected-vs.-observed risks was satisfactory. For given risk factor profiles, there was substantial variation across the four risk regions in the estimated 10-year CVD event risk. CONCLUSIONS: The competing risk-adjusted SCORE2-OP model was derived, recalibrated, and externally validated to estimate 5- and 10-year CVD risk in older adults (aged 70 years or older) in four geographical risk regions. These models can be used for communicating the risk of CVD and potential benefit from risk factor treatment and may facilitate shared decision-making between clinicians and patients in CVD risk management in older persons. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Dariush Mozaffarian; Emelia J Benjamin; Alan S Go; Donna K Arnett; Michael J Blaha; Mary Cushman; Sandeep R Das; Sarah de Ferranti; Jean-Pierre Després; Heather J Fullerton; Virginia J Howard; Mark D Huffman; Carmen R Isasi; Monik C Jiménez; Suzanne E Judd; Brett M Kissela; Judith H Lichtman; Lynda D Lisabeth; Simin Liu; Rachel H Mackey; David J Magid; Darren K McGuire; Emile R Mohler; Claudia S Moy; Paul Muntner; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Graham Nichol; Latha Palaniappan; Dilip K Pandey; Mathew J Reeves; Carlos J Rodriguez; Wayne Rosamond; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Daniel Woo; Robert W Yeh; Melanie B Turner Journal: Circulation Date: 2016-01-26 Impact factor: 29.690
Authors: Donald M Lloyd-Jones; Mark D Huffman; Kunal N Karmali; Darshak M Sanghavi; Janet S Wright; Colleen Pelser; Martha Gulati; Frederick A Masoudi; David C Goff Journal: J Am Coll Cardiol Date: 2016-11-04 Impact factor: 24.094
Authors: Diane E Bild; David A Bluemke; Gregory L Burke; Robert Detrano; Ana V Diez Roux; Aaron R Folsom; Philip Greenland; David R Jacob; Richard Kronmal; Kiang Liu; Jennifer Clark Nelson; Daniel O'Leary; Mohammed F Saad; Steven Shea; Moyses Szklo; Russell P Tracy Journal: Am J Epidemiol Date: 2002-11-01 Impact factor: 4.897
Authors: Jackson T Wright; Jeff D Williamson; Paul K Whelton; Joni K Snyder; Kaycee M Sink; Michael V Rocco; David M Reboussin; Mahboob Rahman; Suzanne Oparil; Cora E Lewis; Paul L Kimmel; Karen C Johnson; David C Goff; Lawrence J Fine; Jeffrey A Cutler; William C Cushman; Alfred K Cheung; Walter T Ambrosius Journal: N Engl J Med Date: 2015-11-09 Impact factor: 91.245
Authors: Johannes A N Dorresteijn; Frank L J Visseren; Paul M Ridker; Annemarie M J Wassink; Nina P Paynter; Ewout W Steyerberg; Yolanda van der Graaf; Nancy R Cook Journal: BMJ Date: 2011-10-03
Authors: Wouter de Ruijter; Rudi G J Westendorp; Willem J J Assendelft; Wendy P J den Elzen; Anton J M de Craen; Saskia le Cessie; Jacobijn Gussekloo Journal: BMJ Date: 2009-01-08
Authors: Oyvind Naess; Anne Johanne Søgaard; Egil Arnesen; Anne Cathrine Beckstrøm; Espen Bjertness; Anders Engeland; Peter F Hjort; Jostein Holmen; Per Magnus; Inger Njølstad; Grethe S Tell; Lars Vatten; Stein Emil Vollset; Geir Aamodt Journal: Int J Epidemiol Date: 2007-11-04 Impact factor: 7.196
Authors: Dorien M Kimenai; Leah Pirondini; John Gregson; David Prieto; Stuart J Pocock; Pablo Perel; Tilly Hamilton; Paul Welsh; Archie Campbell; David J Porteous; Caroline Hayward; Naveed Sattar; Nicholas L Mills; Anoop S V Shah Journal: Circulation Date: 2022-06-24 Impact factor: 39.918
Authors: Isaac Subirana; Anna Camps-Vilaró; Roberto Elosua; Jaume Marrugat; Helena Tizón-Marcos; Ivan Palomo; Irene R Dégano Journal: Clin Epidemiol Date: 2022-10-11 Impact factor: 5.814
Authors: Johannes T Neumann; Moeen Riaz; Andrew Bakshi; Galina Polekhina; Le T P Thao; Mark R Nelson; Robyn L Woods; Gad Abraham; Michael Inouye; Christopher M Reid; Andrew M Tonkin; John McNeil; Paul Lacaze Journal: Circ Genom Precis Med Date: 2021-12-24
Authors: Aline M A Martins; Mariana U B Paiva; Diego V N Paiva; Raphaela M de Oliveira; Henrique L Machado; Leonardo J S R Alves; Carolina R C Picossi; Andréa T Faccio; Marina F M Tavares; Coral Barbas; Viviane Z R Giraldez; Raul D Santos; Guilherme U Monte; Fernando A Atik Journal: Front Cardiovasc Med Date: 2021-12-22
Authors: Shona J Livingstone; Bruce Guthrie; Peter T Donnan; Alexander Thompson; Daniel R Morales Journal: BMC Med Date: 2022-05-04 Impact factor: 11.150